DOA
D'Orazio & Associates’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
17,779
+2,599
| +17% | +$227K | 0.22% | 47 |
|
|
2025
Q1 | $1.04M | Buy |
15,180
+4
| +0% | +$273 | 0.16% | 55 |
|
|
2024
Q4 | $1.18M | Sell |
15,176
-1
| -0% | -$78 | 0.17% | 48 |
|
|
2024
Q3 | $1.02M | Sell |
15,177
-145
| -0.9% | -$9.72K | 0.14% | 56 |
|
|
2024
Q2 | $1.74M | Buy |
15,322
+2,937
| +24% | +$333K | 0.27% | 35 |
|
|
2024
Q1 | $1.72M | Buy |
12,385
+19
| +0.2% | +$2.64K | 0.28% | 33 |
|
|
2023
Q4 | $1.53M | Buy |
12,366
+93
| +0.8% | +$11.5K | 0.27% | 33 |
|
|
2023
Q3 | $1.15M | Buy |
12,273
+1,355
| +12% | +$126K | 0.26% | 39 |
|
|
2023
Q2 | $1.4M | Buy |
10,918
+4,150
| +61% | +$533K | 0.33% | 28 |
|
|
2023
Q1 | $786K | Hold |
6,768
| – | – | 0.2% | 38 |
|
|
2022
Q4 | $766K | Hold |
6,768
| – | – | 0.18% | 43 |
|
|
2022
Q3 | $545K | Buy |
6,768
+1,548
| +30% | +$125K | 0.16% | 50 |
|
|
2022
Q2 | $389K | Buy |
+5,220
| New | +$389K | 0.1% | 72 |
|
|
2022
Q1 | – | Sell |
-387
| Closed | -$208K | – | 111 |
|
|
2021
Q4 | $208K | Hold |
387
| – | – | 0.05% | 96 |
|
|
2021
Q3 | $212K | Buy |
+387
| New | +$212K | 0.05% | 85 |
|